Literature DB >> 9177905

Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix.

M Schlaeppi1, C Rüegg, C Trân-Thang, G Chapuis, H Tevaearai, H Lahm, B Sordat.   

Abstract

Peritoneal carcinomatosis involves a series of events including tumor cell interactions with mesothelial cells and the extracellular matrix (ECM). We have studied the adhesive and invasive properties of four human colorectal carcinoma cell lines (Co115, HT29, SW480, SW620) confronted in vitro with a human mesothelial cell monolayer or with the ECM proteins collagen IV, laminin-1, fibronectin, tenascin-C and vitronectin. Quantitation was achieved following staining of tumor cells with the calcein-AM fluorescent dye. We found that all four cell lines rapidly adhered to a mesothelial cell monolayer. This adhesion event was not inhibitable by anti-integrin and anti-CD44 antibodies. Following initial attachment, the SW480 and SW620 cells invaded the mesothelial cell monolayer more aggressively than HT29 and Co115 cells. All cell lines adhered to ECM proteins with each one exhibiting an individual adhesion pattern. Adhesion to matrix was completely integrin-dependent. When tested in an invasion assay, HT29 and Co115 cells crossed Matrigel-coated filters while SW480 and SW620 cells did not. This invasion was inhibited by anti-beta 1 integrin antibodies. Taken together, our results demonstrate that the initial colorectal tumor cell-mesothelial cell interaction occurs through an integrin-independent mechanism while adhesion to matrix proteins and invasion through Matrigel are integrin-dependent events. Furthermore, the different invasive capacity of SW480 and SW620 versus HT29 and Co115 cells upon interaction with a mesothelial cell monolayer or Matrigel suggests that these two invasion events may be mediated by distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177905     DOI: 10.3109/15419069709004460

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  7 in total

1.  A three-dimensional in-vitro model for the study of peritoneal tumour metastasis.

Authors:  D G Jayne; R O'Leary; A Gill; A Hick; P J Guillou
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

2.  ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention.

Authors:  Nawar A Alkhamesi; Paul Ziprin; Katherine Pfistermuller; David H Peck; Ara W Darzi
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Induction of Proteases in Peritoneal Carcinomatosis, the Role of ICAM-1/CD43 Interaction.

Authors:  Nawar A Alkhamesi; Gretta Roberts; Paul Ziprin; David H Peck
Journal:  Biomark Insights       Date:  2007-10-08

4.  Laparoscopic enhancement of tumour cell binding to the peritoneum is inhibited by anti-intercellular adhesion molecule-1 monoclonal antibody.

Authors:  P Ziprin; P F Ridgway; D H Peck; A W Darzi
Journal:  Surg Endosc       Date:  2003-09-10       Impact factor: 4.584

5.  Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.

Authors:  Giuseppe S Sica; Cristina Fiorani; Carmine Stolfi; Giovanni Monteleone; Eleonora Candi; Ivano Amelio; Valeria Catani; Simone Sibio; Andrea Divizia; Giorgia Tema; Edoardo Iaculli; Achille L Gaspari
Journal:  Oncotarget       Date:  2015-05-30

6.  Tumor cell‑fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer.

Authors:  Qing Han; Bangxing Huang; Zaiju Huang; Jing Cai; Lanqing Gong; Yifan Zhang; Jiahong Jiang; Weihong Dong; Zehua Wang
Journal:  Int J Mol Med       Date:  2019-10-02       Impact factor: 4.101

7.  Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction.

Authors:  R M Heath; D G Jayne; R O'Leary; E E Morrison; P J Guillou
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.